Tessera Therapeutics
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
2
Funding Rounds
$530.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** (J**** Ru**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Tessera Therapeutics has raised a total of $530m in funding over 2 rounds.
Key Insights:
- Tessera Therapeutics Series C round, April 2022: $300m
- Tessera Therapeutics , January 2021: $230m
Tessera Therapeutics Series C round, April 2022
$300m
Tessera Therapeutics , January 2021
$230m
Industries
Tessera Therapeutics is active in the following industries: